Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Contact information


elisabeth.rothweiler@cmd.ox.ac.uk

Social media

Elisabeth Mira Rothweiler

Pharmacist, DPhil in Clinical Medicine

Mira is investigating synthetic nanobodies as ‘molecular Trojan horses’ to facilitate drug delivery to the brain across the blood brain barrier.

She is the Project Lead for the CNS shuttle project at the Oxford Drug Discovery Institute (ODDI) assay development team, and utilises ribosome- and phage-display screens in combination with biophysical and cell-based models to identify novel nanobody shuttles for the brain delivery of therapeutics for Alzheimer’s Disease.

Her postdoctoral work is funded by Alzheimer’s Research UK. She was awarded a Junior Research Fellowship from Kellogg College in 2024 and is a College Lecturer in Medicine at Hertford College. Previously, she obtained a DPhil in Clinical Medicine in the field of chemical biology and targeted protein degradation under co-supervision of Prof Paul Brennan and Dr Kilian Huber.

Mira graduated from the Ludwig Maximilian University in Munich as a licensed Pharmacist and is interested in drug discovery and the development of novel therapeutics for neurodegenerative diseases.

Recent publications

More publications